Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure in the Cattle Health Sector
4.2.2 Rising Burden of Cattle Diseases
4.2.3 Increasing Initiatives by Government and Animal Welfare Associations
4.3 Market Restraints
4.3.1 Lack of Infrastructure and Funding
4.3.2 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product Type
5.1.1 By Therapeutics
5.1.1.1 Vaccine
5.1.1.2 Parasiticide
5.1.1.3 Anti-infective
5.1.1.4 Medical Feed Additive
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Test
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Qiagen
6.1.2 Boehringer Ingelheim
6.1.3 Thermo Fisher Scientific
6.1.4 Elanco Animal Health
6.1.5 Idexx Laboratories
6.1.6 IDVet
6.1.7 Kyoritsuseiyaku Corporation
6.1.8 Merck & Co Inc.
6.1.9 Norbrook
6.1.10 Vetoquinol
6.1.11 Virbac
6.1.12 Zoetis Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS